What Is A Mitochondrial-Derived Peptide?
Mitochondria carry their own small genome. Beyond the well-known genes for respiratory-chain proteins, short open reading frames within mitochondrial ribosomal RNA genes encode a family of bioactive peptides called mitochondrial-derived peptides (MDPs). These peptides are released and act as signaling molecules, communicating the metabolic state of the mitochondria to the rest of the cell and even to distant tissues.
MOTS-c is the best characterized metabolic MDP. It is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA region, and its sequence is highly conserved across species. Because it originates from the mitochondrial genome itself, MOTS-c is studied as an endogenous regulator rather than a foreign compound.
MOTS-c: AMPK Signaling And Nuclear Translocation
In research models, MOTS-c is associated with activation of AMP-activated protein kinase (AMPK), the central cellular energy sensor. It is linked to the folate-methionine one-carbon cycle, with downstream accumulation of AICAR-like intermediates that engage AMPK signaling. The net effect studied in cell and animal models is enhanced insulin sensitivity and glucose handling in skeletal muscle.
A striking feature of MOTS-c is that under metabolic stress it can translocate from the mitochondria into the cell nucleus in an AMPK-dependent manner, where it associates with stress-responsive and antioxidant-response-element (ARE) transcription factors. This positions MOTS-c as a mitochondria-to-nucleus signal that helps coordinate the cell-wide stress response.
MOTS-c is also studied in the context of exercise and aging. Reported observations in the literature include exercise-associated increases in MOTS-c in skeletal muscle and circulation, and age-associated declines in MOTS-c levels in both human and rodent tissue. These are research findings in models and populations, not indications for use.
SS-31 (Elamipretide): A Mitochondria-Targeted Tetrapeptide
SS-31, also known as elamipretide, takes a completely different approach. It is a synthetic aromatic-cationic tetrapeptide (sequence D-Arg-2’,6’-dimethylTyr-Lys-Phe-NH2). Its alternating cationic and aromatic residues let it concentrate several thousand-fold within the inner mitochondrial membrane without depending on membrane potential.
Once there, SS-31 selectively binds cardiolipin, a signature phospholipid of the inner mitochondrial membrane. By associating with cardiolipin it is studied for stabilizing the folded cristae architecture, supporting electron-transport-chain organization and ATP synthesis efficiency, and reducing the generation of reactive oxygen species. In short, MOTS-c is a signal the cell sends; SS-31 is a structural stabilizer that acts on the membrane itself.
- MOTS-c: endogenous 16-aa mitochondrial-derived peptide; signals via AMPK; studied for metabolic homeostasis and stress resistance.
- SS-31: synthetic 4-aa mitochondria-targeted peptide; binds cardiolipin; studied for cristae stability and electron-transport efficiency.
- Different origin, size, target, and mechanism — they are not interchangeable in study design.
Research Areas And Study Models
Both peptides are studied in the broad area of mitochondrial dysfunction, which is relevant to metabolic, cardiovascular, renal, and aging research. SS-31 has been examined in preclinical models of ischemia-reperfusion injury, heart failure, and mitochondrial myopathy, while MOTS-c features in metabolic and exercise-physiology research. Common in vitro readouts include oxygen-consumption-rate assays (Seahorse respirometry), mitochondrial membrane-potential dyes, ATP quantification, and reactive-oxygen-species probes.
As with any Research Use Only compound, the value of these peptides in a study depends on rigorous controls, verified identity and purity, and careful interpretation against the primary literature rather than summary claims.
Research Use Only: This guide is informational and describes research-context handling of compounds intended strictly for in vitro laboratory research. Products are not for human or animal consumption, ingestion, or injection, and are not FDA-approved. Nothing here is medical, clinical, or dosing advice.
Frequently Asked Questions
What is the difference between MOTS-c and SS-31?
MOTS-c is an endogenous 16-amino-acid mitochondrial-derived peptide that signals through AMPK, while SS-31 (elamipretide) is a synthetic tetrapeptide that binds cardiolipin to stabilize the inner mitochondrial membrane. They differ in origin, size, target, and mechanism.
What is a mitochondrial-derived peptide?
A mitochondrial-derived peptide (MDP) is a short peptide encoded within the mitochondrial genome that acts as a signaling molecule. MOTS-c, encoded in the mitochondrial 12S rRNA region, is the best-characterized metabolic MDP.
What is SS-31 studied for?
SS-31 (elamipretide) is studied in mitochondrial-dysfunction research, including preclinical models of ischemia-reperfusion injury, heart failure, and mitochondrial myopathy. It is a Research Use Only compound for in vitro laboratory research only.